FDA ALS Clinical Trial Guidance Released
The big news on Monday, September 23, 2019 was that the FDA ALS Guidance document at last was finalized! With great anticipation, we read and re-read it and were happy to find that so much mapped to the recommendations we provided on August 28, 2019. The recommendation document was a compilation of a multitude of ALS advocate voices since 2013. We ensured this document reflected the time and expertise of so many before us and so many who are no longer with us.
Media Contact: Theresa Garner, [email protected]
We will find cures for ALS. The only question is when. That answer depends on you.
Stay informed on I AM ALS’ progress and what you can do to help us make hope real.
ALS Organizations Unite in Support of AMX0035 Approval
ALS Organizations Unite in Support of AMX0035 Approval. Read their open letter.
Response to NINDS ALS Strategic Plan Request for Information
On Feb 10, 2022 I AM ALS submitted a response to the National Insititute of Neurological Disorders and Stroke (NINDS) ALS Strategic Plan Request for Information. NINDS is a part of the National Institute of Health (NIH), which is the largest public funder of ALS research.